-
Record Number of COVID-19 Hospitalizations Seen in Florida
drugs
August 06, 2021
COVID-19 hospitalizations in Florida reached a new high this week, the Florida Hospital Association (FHA) says.
-
Moderna Vaccine's Protection Does Not Wane After Six Months: Report
drugs
August 06, 2021
Moderna Inc. announced on Thursday that the potency of its vaccine does not dim in the first six months after the second dose.
-
India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
firstwordpharma
August 06, 2021
Panacea Biotec has agreed to produce up to 25 million doses of Russia’s Sputnik V COVID-19 vaccine using the drug substance made by Generium, as reported by Yahoo!News.
-
Centene Announces Additional Actions To Further Protect Members And Employees From COVID-19
prnewswire
August 06, 2021
Centene Corporation (NYSE: CNC) today announced it is taking additional steps to further protect members and employees from COVID-19, to educate its key stakeholders about the benefits of the vaccine, and to prepare for anticipated vaccine.
-
Educational robot Market to Reach US$ 3,327.7 Million at a 20.2% CAGR by 2028 - COVID-19 Impact and Global Analysis by The Insight Partners
prnewswire
August 06, 2021
According to new research study on "Educational Robot Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and Geography," the market is projected to reach US$ 3,327.7 million by 2028 from US$ 794.2 million in 2020.
-
Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19
prnewswire
August 06, 2021
Stemedica announces enrollment of patients for its study entitled "A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Moderate.
-
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
prnasia
August 05, 2021
Novavax announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant.
-
Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test
prnasia
August 05, 2021
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, today announced its qualitative COVID-19 Total N antibody test received U.S. Food and Drug Administration EUA.
-
Government releases ‘National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19’
expresspharma
August 05, 2021
The Government of India has released the “National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19” prepared by the National Task force in consensus from various expert committees, informed Sarbananda Sonowal ...
-
Biden Offers COVID-19 Vaccines to Migrants in Custody Along Mexican Border
drugs
August 05, 2021
COVID-19 vaccines will be offered to migrants in U.S. custody at the Mexican border, federal government officials said Tuesday.